Clinical Trials | Can a new computer formula safely help improve blood sugar levels in people with type 2 diabetes?
Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers: A Pilot Study (TREAT2D)
The Center for Diabetes Technology is seeking adults, ages 18 and older with type 2 diabetes for a research study. The purpose of the study is to see if a new computer formula can safely help improve blood sugar levels in people with type 2 diabetes. We want to find out if using this tool works well and is safe to use. You may be eligible for this study if: you have type 2 diabetes, are 18 years old or older, and take insulin as well as other diabetes medications. If you agree to participate, this study will involve you using your personal insulin pen and wearing a study-provided continuous glucose monitor (CGM) for about 5 months. The study will cover the cost of the CGMs during participation. There are about 14 study visits over the course of the study. All visits may be completed remotely or in-person. Study-related exams may include a hemoglobin A1c test and lab work. The study-related exams and the study supplies are provided at no cost.